This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abbexa
product type :
ELISA/assay
product name :
Human Inactive ubiquitin carboxyl-terminal hydrolase 53 (USP53) ELISA Kit
catalog :
abx384195
quantity :
96 tests
product information
Catalogue Code :
abx384195
Target :
Inactive ubiquitin carboxyl-terminal hydrolase 53 (USP53)
Product Name :
Human Inactive ubiquitin carboxyl-terminal hydrolase 53 (USP53) ELISA Kit
Short Name :
USP53
Category :
ELISA Kits
Size 1 :
96 tests
Size 2 :
5 × 96 tests
Size 3 :
10 × 96 tests
Description :
Human Inactive ubiquitin carboxyl-terminal hydrolase 53 (USP53) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human USP53 concentrations in tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.
UniProt Primary AC :
Q70EK8
UniProt Entry Name :
UBP53_HUMAN
Gene Symbol :
USP53
OMIM :
617431
HGNC :
29255
KEGG :
hsa:54532
Ensembl :
ENSG00000145390
String :
9606.ENSP00000409906
Tested Applications :
ELISA
Storage :
Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
UNSPSC Code :
41116158
Availability :
Shipped within 5-12 working days.
DryIce :
No
company information
Abbexa
Abbexa LTD, Cambridge, UK
Abbexa LLC, Houston, USA
Abbexa LLC, Houston, USA
info@abbexa.com
https://www.abbexa.com44 (0)1223 75595
1 832 327 7413
1 832 327 7413
headquarters: UK
Abbexa is a biotechnology company based in Cambridge, UK, specializing in high quality, reliable research reagents for scientific research. We work in partnership with academic institutions, hospitals and laboratories across the world to bring an integrated source of antibodies, proteins, ELISA kits and other biological reagents. We are dedicated to providing excellent customer service, quality and affordable products to enable scientists to do better science. For more information, please visit http://www.abbexa.com/.
questions and comments